David Grainger - Chief Innovation Officer @ Centessa Pharmaceuticals

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

Primary Job Title Chief Innovation Officer
Primary Organization
Centessa Pharmaceuticals

Location Cambridge, Cambridgeshire, United Kingdom
Regions Europe, Middle East, and Africa (EMEA)
Gender Male

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn
X (Twitter) View on X

David Grainger is the CIO of Centessa Pharmaceuticals. He previously worked at Total Scientific Ltd as an Executive Chairman. David Grainger attended the University of Cambridge.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Rivus Pharmaceuticals	Medicxi	—	Series B - Rivus Pharmaceuticals	obfuscated obfuscation
obfuscated obfuscation	Rivus Pharmaceuticals	Medicxi	Yes	Series A - Rivus Pharmaceuticals	obfuscated obfuscation
obfuscated obfuscation	Critical Pressure	Medicxi	Yes	Series A - Critical Pressure	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

David Grainger

has

current jobs including

Chief Innovation Officer

Centessa Pharmaceuticals

Chief Innovation Officer

Centessa Pharmaceuticals

, and

Co-founder

Foundation Institute for 21st Century Medicine

. Additionally,

David Grainger

has had

past jobs including

Executive Chairman

Total Scientific

Centessa Pharmaceuticals Chief Innovation OfficerOct 2021
Centessa Pharmaceuticals Chief Innovation OfficerOct 2021
Foundation Institute for 21st Century Medicine Co-founderFeb 1, 2018
Medicxi PartnerFeb 2016
RxCelerate CO-FOUNDER and EXECUTIVE CHAIRMANApr 2014
Morphogen-IX Chief Scientific Officer
Z Factor Director
Critical Pressure CEO
Forbes Contributor

Organization Name	Title At Company	Start Date	End Date
Total Scientific	Executive Chairman	Apr 2011	Apr 2018
XO1	Co-Founder	Apr 2013	Jun 2015
University of Cambridge	Principal Investigator	—	Dec 2011
Funxional Therapeutics	Founder & Chief Scientific Officer	—	—
Methuselah Health	CEO	—	—
Epsilon-3 Bio	Founder, CSO & CEO	—	—
Epsilon 3 Bio	Co-Founder	—	—
Index Ventures	Venture Partner	Jan 1, 2012	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

David Grainger

holds

board and advisor roles as

Co-Founder and Chief Scientific Advisor

Medicxi

and

Director

Divide and Conquer

Medicxi Co-Founder and Chief Scientific AdvisorFeb 2016
Divide and Conquer Director

Organization Name	Title At Company	Start Date	End Date
Total Scientific	Executive Chairman of the Board of Directors	Apr 2011	Apr 2018
Funxional Therapeutics	Member of the Board of Directors	—	—

Related Hubs

Hub Name	CB Rank (Hub)
LifeSci Venture Partners Portfolio Companies	90,847
Pharmaceutical Acquired Companies With More Than 100 Employees	14,466
Clinical Trials Companies With More Than 10 Employees	10,072
Wellington Management Portfolio Companies	24,558
IP Group Portfolio Companies	66,708
Clinical Trials Companies With Fewer Than 1000 Employees	8,801
Clinical Trials Acquired Companies	37,568
Life Science Companies that Exited	11,180
Life Science Companies With Fewer Than 1000 Employees	6,084
Acquired Life Science Companies	18,937

Education

David Grainger

studied at

University of Cambridge

, and

University of Cambridge

University of Cambridge M.A., Ph.DNatural Sciences, First Class Hons19861992
University of Cambridge Ph.DNatural Sciences
University of Cambridge MANatural Sciences